Haihong
Haihong Huang, Beijing CN
Patent application number | Description | Published |
---|---|---|
20120071472 | RIMINOPHENAZINES WITH 2-(HETEROARYL)AMINO SUBSTITUENTS AND THEIR ANTI-MICROBIAL ACTIVITY - The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating | 03-22-2012 |
20140031354 | Protein Kinase Inhibitors - The present invention relates to compounds of Formula I: | 01-30-2014 |
20140243327 | RIMINOPHENAZINES WITH 2-(HETEROARYL) AMINO SUBSTITUENTS AND THEIR ANTI-MICROBIAL ACTIVITY - The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating | 08-28-2014 |
20140364436 | Protein Kinase Inhibitors - The present invention relates to compounds of Formula VIII with absolute configuration R or S: | 12-11-2014 |
Haihong Li, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20110263860 | PREPARATION METHODS OF 6-SUBSTITUTED AMINO-3-CYANOQUINOLINE COMPOUNDS AND THE INTERMEDIATES THEREOF - The present invention relates to a method for preparing 6-substituted amino-3-cyanoquinoline compounds (compound A for short) and the intermediates thereof, more particularly, to a compound of the following formula (I), the preparation method thereof, the intermediates thereof and use thereof for preparing the compound A. The compound of the formula (I) is cyclized in the presence of an alkali to give a compound of formula A, wherein W is OH; or the compound of the formula (I) is cyclized in the presence of an alkali, and then chlorinated to give a compound of the formula A, wherein W is Cl. Compared with the known methods in the literature, the method for preparing the compound A from the compound of formula (I) according to the present invention can avoid using high-temperature condition and high boiling point solvents, and is safe and environment-friendly, mild in reaction condition, easy in operation with a high yield and high product purity. | 10-27-2011 |
Haihong Lin, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20150111563 | Service Control Method, Terminal, and Network Device - A service control method, a terminal, and a network device. The method includes measuring, by a terminal, a service status of interaction between the terminal and a network and/or a moving speed of the terminal; and reporting, by the terminal, measured service status information and/or speed information to a network device, so that the network device configures a network parameter of the terminal according to the service status information and/or the speed information. Therefore, a network throughput is improved, and terminal energy consumption is reduced. | 04-23-2015 |
Haihong Tang, Hangzhou CN
Patent application number | Description | Published |
---|---|---|
20150161139 | DATA SEARCH PROCESSING - A search request sent by a user is received to obtain one or more query words included in the search request. Historical operating information relating to a data object in a search result corresponding to the query words is conducted statistics. An attribute of the data object is selected as a specified attribute to generate a probability distribution model of the attribute value on the specified attribute of the data object. A respective probability corresponding to the attribute value of each data object on the specific attribute in the research result corresponding to the search request sent by the current user is calculated by using the probability distribution model. The output rank of the data objects in the search result is adjusted by using the probability. The present techniques improve reasonability of displaying the data objects in the search result and provide more accurate result. | 06-11-2015 |
Haihong Zhao, Beijing CN
Patent application number | Description | Published |
---|---|---|
20150288374 | DYNAMIC ELEMENT MATCHING METHODS AND APPARATUSES - A dynamic element matching method for a multi-unit-element digital-to-analog converter having unit elements comprises several steps. An element selection probability is determined as a function of a number of the unit elements and a digital signal. Next, loop filter output signals are generated as a function of the determined element selection probability and control signals for the unit elements. Certain ones of the unit elements are selected as a function of the generated loop filter output signals. The selected certain ones of the unit elements are activated for output of the converter. | 10-08-2015 |
Haihong Zhong, Guilford, CT US
Patent application number | Description | Published |
---|---|---|
20130244255 | ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF - The present invention relates to antibodies with specificity to GPNMB, and uses of such antibodies. In particular, the present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides biomarkers for evaluating the effects of therapeutic methods and uses of the antibodies with specificity to GPNMB. | 09-19-2013 |
20140302055 | Antibodies Directed to Angiopoietin-like Protein 4 and Uses Thereof - Antibodies directed to the antigen ANGPTL4 and uses of such antibodies. In accordance with the teachings herein, there are provided fully human monoclonal antibodies directed to the antigen ANGPTL4. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided. | 10-09-2014 |